Companies
STOXX 600Health Care· Denmark
NOVO-B
Status-Quo-PlayerNovo Nordisk
$260.40
+1.24%
Open $257.20·Prev $257.20
as of 17 Apr
STATUS-QUO-PLAYER
Power Core
Novo Nordisk's moat is the compounding integration of GLP-1 molecular leadership, proprietary manufacturing scale, and chronic disease lock-in.
Published18 Apr 2026
UniverseSTOXX 600
SectorHealth Care
→
Direction of Movement
lateral
ROC 200
-42.9%
NOVO-B
Novo Nordisk
$260.40
+1.24%
Open $257.20·Prev $257.20
as of 17 Apr
→Fairly Valued
DCF Fair Value: $286.54
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.